Eurasia Invest Ltd., Kazakhstan   Report issue

For profit
Founded: astana Kazakhstan (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2018
NCT03665519
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Eurasia Invest Ltd., Kazakhstan

Active Ingredients

Drugs in Other Trials (3)

mare milk (3 trials)

mare's milk (2 trials)

ursodeoxycholic acid (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 5
  • # of Trial APIs: 3